Results 1 to 10 of about 132,795 (279)

In vitro antibacterial activity of antiretroviral drugs on key commensal bacteria from the human microbiota [PDF]

Frontiers in Cellular and Infection Microbiology, 2023
IntroductionAntiretroviral therapy has improved life expectancy in HIV-infected patients. However, people living with HIV under antiretroviral therapy are at higher risks of developing chronic complications and acquiring multidrug resistant bacteria than
Elisa Rubio-Garcia, Elisa Rubio-Garcia, Elisa Rubio-Garcia, Elisa Rubio-Garcia, Núria Ferrando, Núria Martin, Clara Ballesté-Delpierre, Clara Ballesté-Delpierre, Jose M. Miró, Jose M. Miró, Roger Paredes, Roger Paredes, Roger Paredes, Roger Paredes, Climent Casals-Pascual, Climent Casals-Pascual, Climent Casals-Pascual, Climent Casals-Pascual, Jordi Vila, Jordi Vila, Jordi Vila, Jordi Vila   +21 more
doaj   +2 more sources

Pharmacogenetics of antiretroviral drugs [PDF]

Vojnosanitetski Pregled, 2012
nema
Dragović Gordana, Grbović Leposava, Jevtović Đorđe   +2 more
doaj   +3 more sources

Antiretroviral Drugs Impact Autophagy: Opportunities for Drug Repurposing [PDF]

Frontiers in Bioscience-Landmark
Autophagy is an evolutionarily conserved process in which intracellular macromolecules are degraded in a lysosomal-dependent manner. It is central to cellular energy homeostasis and to quality control of intracellular components.
Laura Cheney, John M. Barbaro, Grace McDermott, Joan W. Berman   +3 more
doaj   +2 more sources

Antiretroviral Drugs Impact Autophagy with Toxic Outcomes [PDF]

Cells, 2021
Antiretroviral drugs have dramatically improved the morbidity and mortality of people living with HIV (PLWH). While current antiretroviral therapy (ART) regimens are generally well-tolerated, risks for side effects and toxicity remain as PLWH must take ...
Laura Cheney, John M. Barbaro, Joan W. Berman   +2 more
doaj   +2 more sources

Nanodelivery of antiretroviral drugs to nervous tissues [PDF]

Frontiers in Pharmacology, 2022
Despite the development of effective combined antiretroviral therapy (cART), the neurocognitive impairments associated with human immunodeficiency virus (HIV) remain challenging. The presence of the blood-brain barrier (BBB) and blood-cerebrospinal fluid
Sodiq Kolawole Lawal, Samuel Oluwaseun Olojede, Oluwaseun Samuel Faborode, Oluwaseun Samuel Faborode, Okikioluwa Stephen Aladeyelu, Matome Nadab Matshipi, Sheu Oluwadare Sulaiman, Sheu Oluwadare Sulaiman, Edwin Coleridge Stephen Naidu, Carmen Olivia Rennie, Onyemaechi Okpara Azu   +10 more
doaj   +2 more sources

Assessing HIV/AIDS patients’ access to antiretroviral drugs using the healthcare accessibility framework: a cross-sectional study from Shandong, China [PDF]

BMC Infectious Diseases
Background Antiretroviral drugs are important for HIV/AIDS patients, but we know little about the real-life barriers patients face in accessing them.
Zhixin Fan, Songlin Zheng, Weiming Cui, Chao Zheng, Qiang Sun, Jia Yin   +5 more
doaj   +2 more sources

Injectable Antiretroviral Drugs: Back to the Future [PDF]

Viruses, 2021
Current HIV treatment regimens provide sustained virologic suppression, at least partially restore the immune system and have limited side effects; however, they do not allow viral eradication and they are burdened by daily pill intake with a life-long ...
Marco Berruti, Niccolò Riccardi, Diana Canetti, Sergio Lo Caputo, Lucia Taramasso, Antonio Di Biagio   +5 more
doaj   +2 more sources

Safety of antiretroviral drugs [PDF]

Arhiv za farmaciju, 2016
Human immunodeficiency virus (HIV), isolated in 1983 by Paster Institute researches, has been recognised as the cause of million fatalies in 21st century.
Anđelković Milena, Buha Aleksandra, Vukomanović Predrag, Matović Vesna   +3 more
doaj   +1 more source

Pharmacovigilance of Antiretroviral Drugs at B.P. Koirala Institute of Health sciences

Journal of Nepal Health Research Council, 2021
Background: Antiretroviral drugs are lifeline for patients living with HIV. Adverse drug reactions can compromise the compliance to antiretroviral therapy.
Deependra Prasad Sarraf, Gajendra Prasad Rauniar, Roshan Chhetri, Shyam Prasad Kafle, Suchana Marahatta, Basudha Khanal, Sanjib Kumar Sharma, Vivek Kattel   +7 more
doaj   +1 more source

Seasonal Variation of Antiretroviral Drug Exposure during the Year: The Experience of 10 Years of Therapeutic Drug Monitoring

Biomedicines, 2021
Although studies show an annual trend for immunosuppressive drugs, particularly during different seasons, no data are available for antiretroviral drugs exposures in different periods of the year. For this reason, the aim of this study was to investigate
Jessica Cusato, Jacopo Mula, Alice Palermiti, Alessandra Manca, Miriam Antonucci, Valeria Avataneo, Elisa Delia De Vivo, Alice Ianniello, Andrea Calcagno, Giovanni Di Perri, Amedeo De Nicolò, Antonio D’Avolio   +11 more
doaj   +1 more source